Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

NCT04966013 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
216
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

EmitBio Inc.